Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis: an Open, Randomized, Controlled Clinical Trial

NCT01455246 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT01455246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis: an Open, Randomized, Controlled Clinical Trial
Lead sponsor
University of Padova
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2010
Completion date
July 31, 2014
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, cirrhosis, nosocomial spontaneous bacterial peritonitis